FI71129C - Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler - Google Patents

Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler Download PDF

Info

Publication number
FI71129C
FI71129C FI801840A FI801840A FI71129C FI 71129 C FI71129 C FI 71129C FI 801840 A FI801840 A FI 801840A FI 801840 A FI801840 A FI 801840A FI 71129 C FI71129 C FI 71129C
Authority
FI
Finland
Prior art keywords
alkyl
enol
compounds
solution
mixture
Prior art date
Application number
FI801840A
Other languages
English (en)
Finnish (fi)
Other versions
FI801840A (fi
FI71129B (fi
Inventor
Gordon Northrop Walker
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI801840A publication Critical patent/FI801840A/fi
Application granted granted Critical
Publication of FI71129B publication Critical patent/FI71129B/fi
Publication of FI71129C publication Critical patent/FI71129C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4162,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI801840A 1979-06-11 1980-06-09 Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler FI71129C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4606379A 1979-06-11 1979-06-11
US4606379 1979-06-11

Publications (3)

Publication Number Publication Date
FI801840A FI801840A (fi) 1980-12-12
FI71129B FI71129B (fi) 1986-08-14
FI71129C true FI71129C (fi) 1986-11-24

Family

ID=21941390

Family Applications (1)

Application Number Title Priority Date Filing Date
FI801840A FI71129C (fi) 1979-06-11 1980-06-09 Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler

Country Status (22)

Country Link
EP (2) EP0021207B1 (pt)
JP (1) JPS562961A (pt)
KR (4) KR840001131B1 (pt)
AT (1) ATE14724T1 (pt)
AU (1) AU539967B2 (pt)
CA (1) CA1133917A (pt)
CY (1) CY1426A (pt)
DD (1) DD151307A5 (pt)
DE (1) DE3070951D1 (pt)
DK (1) DK155996C (pt)
ES (1) ES8104223A1 (pt)
FI (1) FI71129C (pt)
GR (1) GR69239B (pt)
HK (1) HK50288A (pt)
HU (1) HU182670B (pt)
IE (1) IE50288B1 (pt)
IL (1) IL60269A (pt)
KE (1) KE3795A (pt)
NO (1) NO155197C (pt)
NZ (1) NZ193995A (pt)
PT (1) PT71367A (pt)
ZA (1) ZA803461B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127809B (en) * 1982-09-28 1986-03-12 Ciba Geigy Ag Certain b-oxo-a-carbamoyl-pyrrolepropionitriles
DE3247454A1 (de) * 1982-12-22 1984-06-28 Laboratorios Bago S.A., Buenos Aires Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3525623A1 (de) * 1985-07-18 1987-01-22 Celamerck Gmbh & Co Kg Fungizid wirksame acrylsaeureamide
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
GB8619433D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
JPH02502534A (ja) * 1987-12-18 1990-08-16 チバ‐ガイギー アクチェンゲゼルシャフト 1‐メチル‐β‐オキソ‐α‐(フェニルカルバモイル)‐2‐ピロールプロピオニトリルのトロメタミン塩
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
GR880100839A (el) * 1988-12-15 1994-03-31 Ciba Geigy Αλας τρομε?αμίνης του 1-με?ύλ-Β-ΟΞΟ-Α-(φαινυλοκαρβομουλό)-2-πυρρολοπροπιονιτριλίου.
AU625688B2 (en) * 1989-01-31 1992-07-16 Merrell Dow Pharmaceuticals Inc. Method of using aryl- or heteroaryl-1-alkyl-pyrrole-2- carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
GB9720899D0 (en) * 1997-10-01 1997-12-03 Pharmacia & Upjohn Spa Condensed heterocyclic compounds
JP2005520835A (ja) * 2002-03-19 2005-07-14 バイエル ケミカルズ アクチエンゲゼルシャフト 光データキャリアの情報層における吸光性化合物としてのスクアリリウム色素

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE861500C (de) * 1942-07-05 1953-01-05 Beth Ag Maschf Spuelluftfilter
GB1201061A (en) * 1966-08-26 1970-08-05 Endo Lab Oxo pyrroles and process for preparing same
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
NL178596C (nl) * 1975-06-05 1986-04-16 Hoechst Ag Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden.
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten

Also Published As

Publication number Publication date
ES492278A0 (es) 1981-04-01
HK50288A (en) 1988-07-15
IL60269A (en) 1983-12-30
ES8104223A1 (es) 1981-04-01
ATE14724T1 (de) 1985-08-15
KR840001133B1 (ko) 1984-08-09
DK155996B (da) 1989-06-12
KE3795A (en) 1988-03-11
EP0021207B1 (de) 1985-08-07
AU5917380A (en) 1980-12-18
GR69239B (pt) 1982-05-11
FI801840A (fi) 1980-12-12
NO801733L (no) 1980-12-12
NZ193995A (en) 1983-03-15
JPH0351704B2 (pt) 1991-08-07
PT71367A (en) 1980-07-01
DD151307A5 (de) 1981-10-14
KR840004678A (ko) 1984-10-22
DE3070951D1 (en) 1985-09-12
NO155197C (no) 1987-02-25
JPS562961A (en) 1981-01-13
DK250180A (da) 1980-12-12
EP0021207A1 (de) 1981-01-07
KR840001134B1 (ko) 1984-08-09
HU182670B (en) 1984-02-28
EP0143142A2 (de) 1985-06-05
KR840001131B1 (ko) 1984-08-09
DK155996C (da) 1989-11-06
AU539967B2 (en) 1984-10-25
CY1426A (en) 1988-09-02
KR830002708A (ko) 1983-05-30
IL60269A0 (en) 1980-09-16
IE50288B1 (en) 1986-03-19
EP0143142A3 (de) 1985-07-17
CA1133917A (en) 1982-10-19
ZA803461B (en) 1981-06-24
KR840004677A (ko) 1984-10-22
NO155197B (no) 1986-11-17
IE801185L (en) 1980-12-11
KR840001132B1 (ko) 1984-08-09
FI71129B (fi) 1986-08-14

Similar Documents

Publication Publication Date Title
US3635982A (en) Amino-substituted-quinoxalinyloxazolidines and -oxazines
US4943587A (en) Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
FI71129C (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler
DE1595915A1 (de) Verfahren zur Herstellung von heterocyclischen Benzamiden
PL165653B1 (pl) Sposób wytwarzania nowych pochodnych azaoksindolu PL PL PL
US4194003A (en) New pyrrole derivatives, process for their preparation and therapeutic applications thereof
US4816467A (en) Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions and use
FI77227B (fi) Foerfarande foer framstaellning farmakologiskt aktiva 1-metyl-5-p-toluoylpyrrol-2-aettiksyra amider.
EP1317411A1 (en) Derivatives of naphthalene with comt inhibiting activity
DE68910523T2 (de) Trizyklische 3-oxo-propannitril-derivate und verfahren zu deren herstellung.
JPS6019757B2 (ja) 新規チエノ−〔2,3−c〕−及び−〔3,2−c〕−ピリジン誘導体及びその製造方法並びにそれを含有する治療用組成物
FI78084C (fi) Foerfarande foer framstaellning av nya, terapeutiskt verksamma bensopyranderivat.
US4256759A (en) Alphacarbamoyl-pyrrolpropionitriles
US4127585A (en) Isoxazol amides of 4-hydroxy-6H-thieno[2,3-b]thiopyran-5-carboxylic acid-7,7-dioxide
RU2048466C1 (ru) Производные хинолин-2-ил-метоксибензилгидроксимочевины, способ их получения и 4-(хинолин-2-ил-метокси)фенил-циклоалкилкетон в качестве исходного соединения для получения производных хинолин-2-ил-метоксибензилгидроксимочевины
AU599190B2 (en) Condensed pyrazole derivatives and process for their preparation
US4207317A (en) 1-Aryl-4-carbamoyl-pyrazolin-5-ones
US5250541A (en) Kynurenic acid derivatives, their preparation and pharmaceutical compositions containing them
US3564008A (en) Process for preparing 1-acyl-2-phenyl-3-indolylaliphatic acid derivatives
CH498856A (de) Verfahren zur Herstellung von neuen Furazanderivaten
US3703513A (en) Novel 3,5-dioxopyrazolidine derivatives
Ronsisvalle et al. Synthesis and pharmacological properties of N-thienyl alkylenediamines
EP0145304B1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof
PT94904A (pt) Processo para a preparacao de derivados benzotiazinicos e de composicoes farmaceuticas que os contem
RU2128651C1 (ru) Н-бутиламид 2-анилино-6,7-дигидро-5н-пириндин-3-карбоновой кислоты, проявляющий противовоспалительную активность

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CIBA-GEIGY AG